Health ❯Mental Health ❯Depression ❯Treatment
Cancer Psychedelics Psychedelics Psychedelics Depression Clinical Trials Therapeutic Techniques Mental Health Psychiatric Disorders Cancer
More than half of cancer patients in the Phase II trial experienced sustained remission of depressive symptoms with a single dose of psilocybin, prompting researchers to launch repeat-dose studies.